Abstract:Background The increasing incidence of inflammatory bowel disease (IBD) has imposed heavy financial burdens for Chinese patients; however, data about their financial status and access to health care are still lacking. This information is important for informing patients with IBD about disease treatment budgets and health care strategies. Objective The aim of this study was to evaluate the economic status and medical care access of patients with IBD through the China Crohn’s & Colitis Foundation web-based platform in China. Methods Our study was performed in 14 IBD centers in mainland China between 2018 and 2019 through WeChat. Participants were asked to complete a 64-item web-based questionnaire. Data were collected by the Wenjuanxing survey program. We mainly focused on income and insurance status, medical costs, and access to health care providers. Respondents were stratified by income and the associations of income with medical costs and emergency visit times were analyzed. Results In this study, 3000 patients with IBD, that is, 1922 patients with Crohn disease, 973 patients with ulcerative colitis, and 105 patients with undetermined colitis were included. During the last 12 months, the mean (SD) direct and indirect costs for per patient with IBD were approximately US $11,668.68 ($7944.44) and US $74.90 ($253.60) in China. The average reimbursement ratios for most outpatient and inpatient costs were less than 50%. However, the income of 85.5% (2565/3000) of the patients was less than ¥10,000 (US $1445) per month. Approximately 96.5% (2894/3000) of the patients were covered by health insurance, but only 24.7% (741/3000) of the patients had private commercial insurance, which has higher imbursement ratios. Nearly 98.0% (2954/3000) of the patients worried about their financial situation. Thus, 79.7% (2392/3000) of the patients with IBD tried to save money for health care and even delayed their medical treatments. About half of the respondents (1282/3000, 42.7%) had no primary care provider, and 52.2% (1567/3000) of the patients had to visit the emergency room 1-4 times per year for the treatment of their IBD. Multivariate analysis revealed that lower income (P=.001) and higher transportation (P=.004) and accommodation costs (P=.001) were significantly associated with the increased number of emergency visits of the patients. Conclusions Chinese patients with IBD have enormous financial burdens and difficulties in accessing health care, which have increased their financial anxiety and inevitably influenced their disease outcomes. Early purchase of private insurance, thereby increasing the reimbursement ratio for medical expenses, and developing the use of telemedicine would be effective strategies for saving on health care costs.

Network Clinical Collaboration to Improve Quality of Care of Patients with Inflammatory Bowel Disease in China.

Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease

Challenging the Surge of IBD: The role of the China Crohn’s and Colitis Foundation in the healthcare landscape of IBD

IDDF2018-ABS-0223 an Eastern Chinese Multicenter Survey on Health-Related Quality of Life in Inflammatory Bowel Disease Patients and Disease-Related Perception of Caregivers

IDDF2018-ABS-0181 Impact of internet and social media community on patients with inflammatory bowel diseases in china: a multicenter questionnaire survey

Perspectives Of Ibd China: Is Crohn'S And Colitis Foundation Model A Solution To Health Care Issues For The Country?

Economic Burden and Health Care Access for Patients with Inflammatory Bowel Diseases in China: Web-Based Survey Study

Anti-cytokine Therapy and Small Molecule Agents for the Treatment of Inflammatory Bowel Disease

Differences in Inflammatory Bowel Diseases Between East and West: a Chinese Perspective

Review of Inflammatory Bowel Disease in China

Challenging the Surge of IBD: The role of the China Crohn's and Colitis Foundation in the healthcare landscape of IBD.

Quality of Care for Patients with Inflammatory Bowel Disease in East China

Clinical Presentation of Inflammatory Bowel Disease： a Hospital Based Retrospective Study of 379 Patients in Eastern China

Consensus on the Management of Inflammatory Bowel Disease in China in 2007.

Advances in Basic and Clinical Studies on Inflammatory Bowel Disease

Different Therapeutic Approaches on Quality of Life in Patients with Inflammatory Bowel Disease

New concepts on treatment of inflammatory bowel disease

Disease Burden of Inflammatory Bowel Disease in China from 1990 to 2019 and Its Predictions

P479 Trends in Medication Use and Treatment Patterns in Chinese Patients with Inflammatory Bowel Diseases: A Multicenter Cohort Study from 1999 to 2020

Geographical Heterogeneity in the Disease Characteristics and Management of Patients with Inflammatory Bowel Disease, the Preliminary Results of a Chinese Database for IBD (CHASE-IBD)

Surgical Management of Inflammatory Bowel Disease in China: a Systematic Review of Two Decades.